Sanofi continued its growth trajectory. Strong increase in Q1 2021 business EPS at CER.
First quarter 2021 results were reviewed by management during a conference call with the financial community. The presentation was followed by a Q&A session.
- Presentation
- Press release
- Q1 2021 income statements
- Q1 2021 net sales by GBU, franchise, geographic region and product
- R&D appendix
- Download infographic
- Memorandum for modelling purposes
Webcast details
Q1 2021 Results from Sanofi
Q1 2021 infographic
